UPDATE 3-Amgen to buy Celgene psoriasis drug Otezla for $13.4 bln
25 Aug UPDATE 3-Amgen to buy Celgene psoriasis drug Otezla for $13.4 bln
Posted at 14:44h
in
News
by KMFSLLP
Amgen Inc will buy Celgene
Corp’s psoriasis drug Otezla for $13.4 billion in cash,
clearing the way for Bristol-Myers Squibb to go ahead
with its $74 billion deal for Celgene by the end of the year.

Sorry, the comment form is closed at this time.